Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell
Shahzad Maqsood Khan, Syed Sayeed Ahmad, Mohammad Azhar Kamal
Endocrine Metabolic & Immune Disorders - Drug Targets (2020) Vol. 21, Iss. 2, pp. 268-281
Closed Access | Times Cited: 18

Showing 18 citing articles:

Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy
Meng-ling Peng, Yu Fu, Chu-wen Wu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 78
PNGL reduces lipotoxicity in diabetic cardiomyopathy and activates the adiponectin pathway
Jialu Wang, Hongna Tong, Chenyang Zhang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114373-114373
Closed Access
Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy
Huiyan Sun, Dandan Chen, Wenjing Xin, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Circulating mir-199-3p screens the onset of type 2 diabetes mellitus and the complication of coronary heart disease and predicts the occurrence of major adverse cardiovascular events
Renjie Ruan, Yanwei Liu, Xiang Zhang
BMC Cardiovascular Disorders (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Epicardial Adipose Tissue and Diabetic Cardiomyopathy
Xueyuan Yang, Chao Feng, Jinping Feng
Journal of Cardiovascular Pharmacology and Therapeutics (2023) Vol. 28
Open Access | Times Cited: 7
Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1α Signaling Pathway and Suppressing Oxidative Stress
Han Zhimin, Danyang Zhao, Mengfan Han, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 11
siRNA a promising tool for diabetes complications
Moqbel Ali Moqbel Redhwan, Hariprasad M.G, Suman Samaddar, et al.
OpenNano (2023) Vol. 13, pp. 100174-100174
Open Access | Times Cited: 5
Noncoding RNAs as therapeutic targets in autophagy-related diabetic cardiomyopathy
Mohammed Khaled Bin Break, Rahamat Unissa Syed, Weiam Hussein, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155225-155225
Closed Access | Times Cited: 1
Effective protective mechanisms of HO-1 in diabetic complications: a narrative review
Jingjing Zhang, Ping Ni, Yi Song, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Focal adhesion kinase induces cardiac remodeling through NF-κB-mediated inflammatory responses in diabetic cardiomyopathy
Bo Jin, Jiong Wang, Yi Chen, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110280-110280
Closed Access | Times Cited: 4
Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus
Volker H. Schmitt, Jürgen H. Prochaska, A. Föll, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 7
A Review on the Natural Products in Treatment of Diabetic Cardiomyopathy (DCM)
Pengyu Yao, Xiaoni Yang, Yun Qiao
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 5
Open Access
Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics
Sagnik Nag, Oishi Mitra, Bhanu Maturi, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 3, pp. 100927-100927
Open Access
Diabetic Cardiomyopathy: Role of Cell Death, Exosomes, Fibrosis and Epicardial Adipose Tissue
Antonella Galeone, Alessia Annicchiarico, Cinzia Buccoliero, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9481-9481
Open Access
System pharmacology-based determination of the functional components and mechanisms in chronic heart failure treatment: an example of Zhenwu decoction
Yisheng Huang, Qin‐Wen Liu, Meiyu Liu, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 23, pp. 12935-12953
Closed Access | Times Cited: 1
Old and Novel Predictors for Cardiovascular Risk in Diabetic Foot Syndrome—A Narrative Review
Cristina Andreea Adam, Dragoș Traian Marius Marcu, Ovidiu Mitu, et al.
Applied Sciences (2023) Vol. 13, Iss. 10, pp. 5990-5990
Open Access
Herzinsuffizienz bei Typ-2-Diabetes mellitus: Galectin-3 prädiziert diastolische Dysfunktion
Volker H. Schmitt, Omar Hahad, Karsten Keller, et al.
Deutsches Ärzteblatt (2022)
Open Access
Research Progress of Multimodal MR Technology in Diabetic Cardiomyopathy
旭 李
Advances in Clinical Medicine (2022) Vol. 12, Iss. 09, pp. 8082-8087
Closed Access
Page 1

Scroll to top